切换至 "中华医学电子期刊资源库"

中华疝和腹壁外科杂志(电子版) ›› 2026, Vol. 20 ›› Issue (05) : 487 -494. doi: 10.3877/cma.j.issn.1674-392X.2026.05.002

论著

盆底全切除后空盆腔重建技术递进:389例临床数据分析
陈国良1, 王思琦2, 苗佳2, 胡根3, 彭欢1, 苏宁1, 邵国益3, 张剑1,†()   
  1. 1200003 上海,海军军医大学第二附属医院肛肠外科
    2200050 上海,海军军医大学第905医院普外二科
    3214400 江苏江阴,南通大学附属江阴医院 江阴市人民医院城中院区普外一科
  • 收稿日期:2026-09-14 出版日期:2026-10-18
  • 通信作者: 张剑
  • 基金资助:
    军队高层次科技创新人才工程学科拔尖人才计划(第(2020)BJ06038); 上海市东方学者(SHSDFXZZJ); 军队临床重点专科建设项目(JDLCZDZK-ZJ)

Stepwise evolution of empty pelvis reconstruction after total pelvic floor excision: A clinical analysis of 389 cases

Guoliang Chen1, Siqi Wang2, Jia Miao2, Gen Hu3, Huan Peng1, Ning Su1, Guoyi Shao3, Jian Zhang1,†()   

  1. 1Department of Colorectal Surgery, The Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China
    2Department of General Surgery (Division II ), Affiliated the 905th Hospital of Naval Medical University, Shanghai 200050, China
    3Department of General Surgery (Division I), Affiliated Jiangyin Hospital of Nantong University, Jiangyin People's Hospital (Chengzhong Campus), Jiangyin 214400, China
  • Received:2026-09-14 Published:2026-10-18
  • Corresponding author: Jian Zhang
引用本文:

陈国良, 王思琦, 苗佳, 胡根, 彭欢, 苏宁, 邵国益, 张剑. 盆底全切除后空盆腔重建技术递进:389例临床数据分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(05): 487-494.

Guoliang Chen, Siqi Wang, Jia Miao, Gen Hu, Huan Peng, Ning Su, Guoyi Shao, Jian Zhang. Stepwise evolution of empty pelvis reconstruction after total pelvic floor excision: A clinical analysis of 389 cases[J/OL]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2026, 20(05): 487-494.

目的

系统描述扩大盆腔廓清术(EPE)后4个阶段递进式盆底重建的临床实施、基线特征、术中数据、术后恢复、空盆腔综合征(EPS)并发症分布,呈现389例单中心资料全貌,为标准化盆底重建提供依据。

方法

本研究为基于前瞻性中国盆腔脏器联合切除数据库的回顾性描述性研究。连续纳入2021年11月至2026年1月于海军军医大学第二附属医院行盆底整块切除的EPE盆腔肿瘤患者389例。按盆底重建、空腔填塞、创面处理、放疗患者消化道重建分为四个阶段。记录各阶段人口学、术前基线、术中指标、术后恢复及并发症。本研究为描述性研究,不进行4个阶段组间假设检验。

结果

4个阶段技术逐级增加:生物补片→大网膜填塞→分期负压创面管理→放疗高危患者回盲部预防性切除。4个阶段各阶段手术时长中位数520~560 min、出血量中位数740~880 ml,R0切除率80.0%~86.2%。会阴创面处理由一期缝合逐步转为敞开分期负压管理。各阶段术后排气时间中位数60~72 h,引流管留置时间中位数50~80 d、住院时间中位数38~75 d,空盆腔痊愈时间中位数62~82 d。ClavienDindo<Ⅲ级并发症52.8%~68.0%,围手术期死亡仅见于前两阶段。第四阶段(n=36)未观察到肠瘘、肠会阴瘘、盆腔出血、皮瓣相关并发症(0/36),受样本量限制尚待验证,仍存在盆腔深部积液、肠梗阻、泌尿系重度并发症。

结论

4个阶段递进策略可逐层优化盆底修复、创面管理及放疗高危患者个体化处理,观察到EPS相关重度并发症数量呈下降趋势,有助于改善围手术期安全与创面愈合质量,可为EPS精准防控与加速康复提供临床借鉴。

Objective

To systematically describe the clinical implementation of four-stage progressive pelvic floor reconstruction following extended pelvic exenteration (EPE), including baseline characteristics, intraoperative parameters, postoperative recovery, and the distribution of complications related to empty pelvis syndrome (EPS). A total of 389 cases from a single center were included, so as to provide comprehensive overview and evidence for standardized pelvic floor reconstruction.

Methods

This retrospective descriptive study extracted data from a prospective Chinese pelvic exenteration database. A total of 389 consecutive pelvic tumor patients receiving EPE with en bloc pelvic floor resection at the Second Affiliated Hospital of Naval Medical University from November 2021 to January 2026 were included. Reconstruction was categorized into four stages according to pelvic floor repair, pelvic cavity obliteration, wound management and gastrointestinal reconstruction for radiated patients. Demographics, preoperative baseline, intraoperative indicators, postoperative recovery and complication data were collected. Given its descriptive nature, no intergroup hypothesis tests between four stages were performed.

Results

The four-stage technique was implemented in a stepwise manner: biological mesh reconstruction→greater omental packing→staged negative-pressure wound therapy→prophylactic ileocecal resection for high-risk patients receiving radiotherapy. The median operative duration across the four stages ranged from 520 to 560 min, median blood loss ranged from 740 to 880 ml, and R0 resection rate ranged from 80.0% to 86.2%. Perineal wound management evolved from primary closure to open staged negative-pressure therapy. The median time to first postoperative flatus across the four stages was 60 to 72 hours, drainage tube indwelling duration was 50 to 80 days, hospital stay was 38 to 75 days, and time to complete healing of the empty pelvis was 62 to 82 days. The proportion of complications with Clavien-Dindo grade<Ⅲ ranged from 52.8% to 68.0%. Perioperative mortality was only observed in the first two stages. In Stage 4 (n=36), no enterocutaneous fistula, perineoenteric fistula, pelvic hemorrhage or flap-related complications were observed (0/36). This finding remains to be validated due to limited sample size; deep pelvic collection, bowel obstruction and severe urological complications still existed.

Conclusion

The four-stage progressive strategy achieves layered optimization of pelvic floor repair, wound management and individualized intervention for radiotherapy-high-risk patients. Reduced severe EPS-associated complications were noted, which is conducive to improving perioperative safety and wound healing quality, and offering clinical reference for precise EPS prevention and enhancedrecovery.

表1 盆腔廓清术的分类与手术标准
手术分型 手术切除范围 >50%切除标准
骨盆腔内盆腔廓清术 消化系统 直肠/结肠和系膜、肛管/外括约肌复合体 至少1个模块
泌尿系统 膀胱、膀胱-输尿管连接部、盆腔段输尿管、尿道 至少2个模块组织
生殖系统 女性:子宫/宫颈、卵巢/输卵管、阴道/阴道口、小阴唇/阴蒂 至少2个模块组织
男性:精囊腺/输精管、前列腺、球海绵体/坐骨海绵体肌肉/外生殖器、睾丸 至少2个模块组织
联合骨盆壁盆腔廓清术 侧盆 第一层:髂血管蒂-闭孔内肌-耻骨,包括髂总/髂外动静脉、髂内主干/前干/后干血管及属支,侧方淋巴结,闭孔内肌(肛提肌腱弓以上),耻骨联合上半部,耻骨前支(髂外血管内侧)
第二层:神经平面,包括闭孔神经、腰骶干、骶神经、梨状肌
第三层:盆壁和盆壁外组织,包括坐骨大孔、髂骨/髋臼骨盆壁外结构(坐骨神经主干等)
至少第一层">50%组织"被切除:髂内主干、前干或后干,以及髂总或髂内动静脉中至少一支及其所有分支
盆底 第一层:肛提肌/骶前组织,包括骶4~5神经根/骶前组织、肛提肌(坐骨肌、髂尾肌、耻尾肌)、肛提肌腱弓、尿生殖膈 至少一层的">50%"组织被切除
第二层:骨/韧带,包括骶4~5/尾骨、闭孔内肌(肛提肌腱弓下)、骶棘韧带、坐骨棘、骶结节韧带、坐骨直肠窝
第三层:闭孔外组织、臀大肌/上、下孖肌、坐骨结节、坐骨小孔、耻骨后支、耻骨联合下半部
后盆 骶1~3的骶前组织、神经根和骶骨(双侧骶髂关节内侧) 骶1~3至少1节骶骨被切除且骶前组织和骶神经根至少一种被切除
前盆壁 双侧髂前上棘下缘与耻骨梳韧带连线范围内的髂腹股沟区和前腹壁 至少一侧髂腹股沟区的50%以上组织被切除
表2 4个阶段盆底重建递进技术方案
表3 4组合并盆底整块切除的扩大盆腔廓清术患者术前基线资料
观察项目 第一阶段(n=25) 第二阶段(n=183) 第三阶段(n=145) 第四阶段(n=36)
性别[例(%)]
男性 15(60.0) 106(57.9) 80(55.2) 21(58.3)
女性 10(40.0) 77(42.1) 65(44.8) 15(41.7)
年龄[岁,M(P25,P75)] 55.0(48.0,62.0) 57.0(49.0,64.0) 56.0(49.0,63.0) 56.5(49.0,64.0)
体重指数[kg/m2,M(P25,P75)] 24.8(23.7,26.8) 24.2(22.4,25.8) 23.1(21.6,24.8) 22.4(20.6,23.8)
肿瘤类别[例(%)]
结直肠 16(64.0) 122(66.7) 87(60.0) 23(63.9)
泌尿系 3(12.0) 31(16.9) 29(20.0) 5(13.9)
妇科 2(8.0) 14(7.7) 13(9.0) 4(11.1)
肛门 3(12.0) 10(5.5) 11(7.6) 2(5.6)
其他 1(4.0) 6(3.3) 5(3.4) 2(5.6)
肿瘤性质[例(%)]
原发 14(56.0) 96(52.5) 77(53.1) 19(52.8)
复发 11(44.0) 83(45.4) 63(43.4) 17(47.2)
良性 / 4(2.2) 5(3.4) /
盆腔外转移[例(%)] 4(16.0) 28(15.3) 20(13.8) 6(16.7)
术前放化疗[例(%)]
药物化疗 21(84.0) 159(86.9) 109(75.2) 27(75.0)
药物化疗+放疗 16(64.0) 92(50.3) 74(51.0) 16(44.4)
二次放疗 3(12.0) 37(20.2) 20(13.8) 5(13.9)
营养状况[g/L,M(P25,P75)]
血红蛋白 103.8(92.5, 118.2) 107.4(93.1, 122.4) 111.4(95.7, 124.5) 109.8(96.5, 125.8)
白蛋白 28.8(26.4, 31.9) 29.1(26.8, 32.3) 29.5(27.1, 32.7) 29.3(27.2, 32.8)
美国麻醉医师协会分级[例(%)]
Ⅰ 1(4.0) 10(5.5) 8(5.5) 2(5.6)
Ⅱ 14(56.0) 89(48.6) 71(49.0) 19(52.8)
Ⅲ 8(32.0) 75(41.0) 59(40.7) 13(36.1)
Ⅳ 2(8.0) 9(4.9) 7(4.8) 2(5.6)
合并症[例(%)]
高血压 6(24.0) 47(25.7) 38(26.2) 9(25.0)
肾脏病 1(4.0) 18(9.8) 13(9.0) 3(8.3)
心脏疾病 / 8(4.4) 5(3.4) /
糖尿病 2(8.0) 22(12.0) 16(11.0) 3(8.3)
慢性阻塞性肺疾病 3(12.0) 20(10.9) 13(9.0) 2(5.6)
表4 4组合并盆底整块切除的扩大盆腔廓清术患者手术及术后恢复情况
观察项目 第一阶段(n=25) 第二阶段(n=183) 第三阶段(n=145) 第四阶段(n=36)
手术时间[min,M(P25, P75)] 560(480,760) 530(460,780) 520(460,790) 540(470,830)
术中出血量[ml,M(P25,P75)] 880(580,1400) 800(540,1300) 840(580,1380) 740(500,1150)
手术切除范围[例(%)]
骨盆腔内盆腔廓清术
消化系统 23(92.0) 167(91.3) 132(91.0) 33(91.7)
泌尿系统 20(80.0) 152(83.1) 107(73.8) 27(75.0)
生殖系统 18(72.0) 134(73.2) 96(66.2) 24(66.7)
联合骨盆壁盆腔廓清术
侧盆壁 11(44.0) 73(39.9) 87(60.0) 21(58.3)
后盆壁 12(48.0) 81(44.3) 98(67.6) 24(66.7)
盆底 25(100.0) 183(100.0) 145(100.0) 36(100.0)
前盆壁 4(16.0) 24(13.1) 27(18.6) 7(19.4)
切缘[例(%)]
R0 20(80.0) 153(83.6) 125(86.2) 31(86.1)
R1 3(12.0) 18(9.8) 11(7.6) 3(8.3)
姑息 2(8.0) 8(4.4) 7(4.8) 2(5.6)
良性 / 4(2.2) 2(1.4) /
泌尿系重建[例(%)]
回肠代膀胱 7(28.0) 63(34.4) 31(21.4) 6(16.7)
结肠代膀胱 2(8.0) 33(18.0) 38(26.2) 7(19.4)
输尿管经皮肤造口 8(32.0) 29(15.8) 20(13.8) 7(19.4)
肾盂穿刺 2(8.0) 12(6.6) 7(4.8) 3(8.3)
输尿管膀胱再植 1(4.0) 14(7.7) 11(7.6) 4(11.1)
骶尾-会阴切口初始处理方式[例(%)]
一期缝合 22(88.0) 165(90.2) 11(7.6) 2(5.6)
一期皮瓣移植 3(12.0) 18(9.8) 5(3.4) 0(0.0)
切口敞开+负压管理 0(0.0) 0(0.0) 129(89.0) 34(94.4)
计划二期皮瓣转移 1(4.0) 6(3.3) 18(12.4) 2(5.6)
术后排气时间[h,M(P25, P75)] 60(50,80) 70(52,88) 68(50,82) 72(52,85)
引流管留置时间[d,M(P25, P75)] 80(58,92) 68(50,80) 60(45,72) 50(38,60)
住院时间[d,M(P25, P75)] 38(35,42) 45(40,50) 72(58,80) 75(60,82)
创面愈合时间[d,M(P25, P75)] 78(48,105) 50(40,62) 58(48,72) 58(48,68)
空盆腔痊愈时间[d,M(P25, P75)] 82(52,105) 68(56,78) 66(50,76) 62(50,70)
表5 4组合并盆底整块切除的扩大盆腔廓清术患者术后并发症情况[例(%)]
[1]
Cibula D, Lednický Š, Höschlová E, et al. Quality of life after extended pelvic exenterations[J]. Gynecol Oncol, 2022, 166(1): 100-107.
[2]
Bogner A, Fritzmann J, Müssle B, et al. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome[J]. Int J Colorectal Dis, 2021, 36(8): 1701-1710.
[3]
West CT, Tiwari A, Salem Y, et al. A Prospective Observational Cohort Study Comparing High-Complexity Against Conventional Pelvic Exenteration Surgery[J]. Cancers(Basel), 2025, 17(1): 111.
[4]
陈佳威, 彭欢, 陶禹, 等. 盆腔脏器联合切除手术定义和侧盆解剖要点与难点[J]. 中国实用外科杂志, 2026, 46(2): 216-222.
[5]
Brown KGM, Solomon MJ, Koh CE, et al. Defining benchmarks for pelvic exenteration surgery: A multicentre analysis of patients with locally advanced and recurrent rectal cancers[J]. Ann Surg, 2025, 282(6): 1118-1126.
[6]
West CT, Tiwari A, Smith J, et al. Empty pelvis syndrome as a cause of major morbidity after pelvic exenteration: validation of a core data set[J]. Br J Surg, 2025, 112(5): znaf070.
[7]
Jackisch J, Jackisch T, Roessler J, et al. Tailored concept for the plastic closure of pelvic defects resulting from extralevator abdominoperineal excision(ELAPE) or pelvic exenteration[J]. Int J Colorectal Dis, 2022, 37(7): 1669-1679.
[8]
PelvEx Collaborative. The empty pelvis syndrome: a core data set from the PelvEx collaborative[J]. Br J Surg, 2024, 111(3): znae042.
[9]
Lee P, Tan WJ, Brown KGM, et al. Addressing the empty pelvic syndrome following total pelvic exenteration: does mesh reconstruction help?[J]. Colorectal Dis, 2019, 21(3): 365-369.
[10]
中国盆腔脏器联合切除协作组, 中国医师协会结直肠肿瘤专业委员会, 中国医疗保健国际交流促进会胃肠外科学分会. 超全直肠系膜切除层面的原发性直肠癌和局部复发直肠癌盆腔脏器联合切除中国专家共识(2023版)[J]. 中华胃肠外科杂志, 2023, 26(1): 16-26.
[11]
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg, 2004, 240(2): 205-213.
[12]
Steffens D, Solomon MJ, Lee P, et al. Surgical, survival and quality of life outcomes in over 1000 pelvic exenterations: lessons learned from a large Australian case series[J]. ANZ J Surg, 2023, 93(5): 1232-1241.
[13]
Johnson YL, West MA, Gould LE, et al. Empty pelvis syndrome: a systematic review of reconstruction techniques and their associated complications[J]. Colorectal Dis, 2022, 24(1): 16-26.
[14]
Sutton PA, Brown KGM, Ebrahimi N, et al. Long-term surgical complications following pelvic exenteration: operative management of the empty pelvis syndrome[J]. Colorectal Dis, 2022, 24(12): 1491-1497.
[15]
陈国良, 王虞鹭, 张鑫, 等. 基底膜生物补片重建盆底在局部晚期或局部复发直肠癌盆腔脏器联合切除术中的临床应用[J]. 中华胃肠外科杂志, 2023, 26(3): 268-276.
[16]
胡根, 赵振国, 仲卫冬, 等. 盆腔脏器联合切除术术后空盆腔综合征的防治[J]. 结直肠肛门外科, 2025, 31(1): 11-15.
[17]
Blok RD, Hagemans JAW, Klaver CEL, et al. A systematic review and meta-analysis on omentoplasty for the management of abdominoperineal defects in patients treated for cancer[J]. Ann Surg, 2020, 271(4): 654-662.
[18]
陈国良, 王虞鹭, 谢奇峰, 等. 带蒂大网膜瓣联合基底膜生物补片重建盆底在合并骶尾骨的盆腔脏器联合切除术中的临床应用[J]. 中华胃肠外科杂志, 2024, 27(11): 1162-1167.
[19]
Bocková M, Hoch J, Kestlerová A, et al. The dead space after extirpation of rectum. Current management and searching for new materials for filling[J]. Physiol Res, 2019, 68(Suppl 4): S509-S515.
[20]
Komono A, Yoshimatsu G, Kajitani R, et al. Reconstruction with omental flap and negative pressure wound therapy after total pelvic exenteration of anal fistula cancer: a case report[J]. Surg Case Rep, 2022, 8(1): 116.
[21]
马腾辉, 王辉, 汪建平. 慢性放射性肠损伤的手术难点与对策[J]. 中华胃肠外科杂志, 2020, 23(8): 728-733.
[22]
徐田磊, 王峰, 刘伯涛, 等. 12例患者接受基于肠系膜引导的机器人辅助慢性放射性肠炎确定性手术的临床疗效分析[J]. 结直肠肛门外科, 2025, 31(1): 27-33.
[23]
曹煜, 秦启元, 马腾辉. 盆腔放疗继发小肠血管肉瘤1例[J]. 中华胃肠外科杂志, 2025, 28(7): 788-790.
[24]
Didier J, Joly F, Cros J, et al. Clinicopathologic features and postoperative outcome of the radiation-induced enteritis: a retrospective study of 41 patients[J]. Ann Pathol, 2020, 40(6): 426-435.
[25]
Henson CC, Andreyev HJ, Symonds RP, et al. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists[J]. Clin Oncol(R Coll Radiol), 2011, 23(8): 552-557.
[26]
何炎炯, 周佐霖, 秦启元, 等. 全盆腔脏器切除治疗盆腔放射性损伤晚期并发症的初步经验[J]. 中华胃肠外科杂志, 2023, 26(10): 940-946.
[27]
Gamboa-Hoil SI, Gamboa-Gutiérrez R, Medina-Campos A. The Gamboa-Hoil Point for Primary Perineal Closure During Total Pelvic Exenteration[J]. Cureus, 2026, 18(1): e101035.
[28]
Gologorsky R, Arora S, Dua A. Negative-Pressure Wound Therapy to Reduce Wound Complications after Abdominoperineal Resection[J]. Perm J, 2020, 24: 19. 173
[29]
Sumrien H, Newman P, Burt C, et al. The use of a negative pressure wound management system in perineal wound closure after extralevator abdominoperineal excision(ELAPE) for low rectal cancer[J]. Tech Coloproctol, 2016, 20(9): 627-631.
[30]
Ohno R, Yoshimatsu G, Itatani Y, et al. Prophylactic negative pressure wound therapy with Prevena™ to prevent perineal surgical site infection[J]. Surg Today, 2025, 55(12): 1945-1952.
[31]
Griffin N, Rabouhans J, Grant LA, et al. Pelvi-perineal flap reconstruction: normal imaging appearances and post-operative complications on cross-sectional imaging[J]. Insights Imaging, 2011, 2(3): 215-223.
[32]
Kalev G, Buettner S, El-Ahmar M, et al. Reconstruction of the perineal defect after abdominoperineal resection with vertical rectus abdominis myocutaneous(VRAM) flap versus primary direct closure-a single center retrospective cohort study[J]. Langenbecks Arch Surg, 2025, 410(1): 217.
[33]
陶禹, 王虞鹭, 朱鴷, 等. 采用臀大肌皮瓣进行盆底重建治疗盆腔脏器联合切除术后会阴伤口愈合失败患者的疗效分析[J]. 中华胃肠外科杂志, 2025, 28(1): 81-85.
[1] 王燕妮. AI在创面管理中的潜力与挑战[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(04): 320-320.
[2] 侯刘进, 贺智翔, 戴清清, 黄帆, 耿小平, 赵红川, 汪正广. 三种同期手术切除方式治疗结直肠癌肝转移的安全性和预后比较[J/OL]. 中华普通外科学文献(电子版), 2026, 20(05): 291-296.
[3] 孙浩, 郑政, 叶少炜, 钟思权, 雒洪志, 冯春在, 陈宏, 周仕海. 优化共同开口关闭技术在3D腹腔镜右半结肠癌根治术Overlap吻合中的应用[J/OL]. 中华普通外科学文献(电子版), 2026, 20(04): 252-256.
[4] 杨敏, 杜峻峰, 辛林璞. 腹腔镜胃癌根治术后常见并发症防治与管理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(04): 352-355.
[5] 贾亚南, 尚迎晓, 甄江涛. 乳腺术后皮下高引流量淋巴漏1例[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 303-304.
[6] 杨永君, 王槐志. 腹腔镜胰十二指肠切除术主要并发症及处理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 215-218.
[7] 辛林璞, 杨敏, 杜峻峰. 腹腔镜结直肠癌根治术后常见并发症防治与管理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 248-251.
[8] 赵军抗, 张前进, 庄惠杰. 腹腔镜直肠癌根治术保留左结肠动脉的疗效及对预后的影响[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 257-260.
[9] 石兵强, 支永发, 牛闻宇, 张义, 马明杰, 任孝德. 胃癌术后并发症对患者术后生命质量影响研究[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 271-274.
[10] 仲卫冬, 胡根, 刘金春, 戴丽强, 王镇, 浦凌宵, 耿良栋, 邵国益. 带蒂肌皮瓣转移盆底重建防治全盆腔脏器切除术后空盆腔综合征[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(05): 481-486.
[11] 黄伟, 林湘杰, 吴俊文, 胡浩, 杨雪菲. 部分可吸收补片在腹腔镜腹股沟疝修补术中有效性和安全性的Meta分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(04): 461-470.
[12] 李鹏, 冯文博, 王延成, 张佩, 马红霞. 超选择血管介入联合髓芯减压植骨术治疗股骨头缺血性坏死的疗效及对术后并发症的影响[J/OL]. 中华老年骨科与康复电子杂志, 2026, 12(04): 236-242.
[13] 王亚楠, 宋岩, 王胤, 郭城, 陈俊涛, 李锋, 苑小雷. 术前血小板聚集功能与凝血指标预测老年胃肠肿瘤患者术后并发症的价值[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(03): 199-205.
[14] 孙杰, 杨亮, 黄春燕, 史云桃, 刘瑶. 不同介入栓塞方式治疗脾动脉瘤的回顾性临床研究[J/OL]. 中华介入放射学电子杂志, 2026, 14(03): 272-277.
[15] 吴立刚, 曾汉强, 张志成, 陈泉. 锁骨下静脉与颈内静脉入路完全植入式输液港在肿瘤患者中的应用及导管异位相关因素分析[J/OL]. 中华介入放射学电子杂志, 2026, 14(03): 299-306.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?